Latest Callan Capital, LLC Stock Portfolio

Callan Capital, LLC Performance:
2025 Q1: -1.63%YTD: -1.63%2024: -5.56%

Performance for 2025 Q1 is -1.63%, and YTD is -1.63%, and 2024 is -5.56%.

About Callan Capital, LLC and 13F Hedge Fund Stock Holdings

Callan Capital, LLC is a hedge fund based in LA JOLLA, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.5 Billions. In it's latest 13F Holdings report, Callan Capital, LLC reported an equity portfolio of $1.4 Billions as of 31 Mar, 2025.

The top stock holdings of Callan Capital, LLC are FNDA, META, FNDA. The fund has invested 9.4% of it's portfolio in SCHWAB STRATEGIC TR and 8.1% of portfolio in META PLATFORMS INC.

The fund managers got completely rid off DBX ETF TR (HYRM), DANAHER CORPORATION (DHR) and QIAGEN NV stocks. They significantly reduced their stock positions in SPDR DOW JONES INDL AVERAGE (DIA), STELLANTIS N.V and PFIZER INC (PFE). Callan Capital, LLC opened new stock positions in PRIMO BRANDS CORPORATION, SPDR SER TR (BIL) and TAKEDA PHARMACEUTICAL CO LTD (TAK). The fund showed a lot of confidence in some stocks as they added substantially to ORIX CORP (IX), QUANTUM SI INC (QSI) and ISHARES TR (IJR).

Callan Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Callan Capital, LLC made a return of -1.63% in the last quarter. In trailing 12 months, it's portfolio return was -9.04%.
2019202020212022202320242025−2002040Performance (%)PerformanceS&P 500

New Buys

Ticker$ Bought
primo brands corporation5,167,590
spdr ser tr1,231,540
spdr ser tr986,678
berkshire hathaway inc del798,442
takeda pharmaceutical co ltd734,950
vanguard bd index fds488,736
spdr ser tr387,787
mondelez intl inc371,682

New stocks bought by Callan Capital, LLC

Additions

Ticker% Inc.
orix corp496
quantum si inc464
ishares tr217
vanguard index fds180
ishares inc152
american intl group inc123
dyadic intl inc del86.79
sanofi81.66

Additions to existing portfolio by Callan Capital, LLC

Reductions

Ticker% Reduced
spdr dow jones indl average-44.88
stellantis n.v-43.16
pfizer inc-36.17
vanguard intl equity index f-31.68
cgi inc-25.89
thermo fisher scientific inc-24.19
vanguard mun bd fds-23.67
regeneron pharmaceuticals-16.5

Callan Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
redwood trust inc-163,250
western un co-138,468
keycorp-174,777
dbx etf tr-332,962
equinor asa-221,691
know labs inc-63,677
qiagen nv-284,547
invesco exch traded fd tr ii-241,250

Callan Capital, LLC got rid off the above stocks

Sector Distribution

Callan Capital, LLC has about 77.5% of it's holdings in Others sector.

79%10%
Sector%
Others77.5
Communication Services9.6
Technology6.4
Healthcare1.5
Consumer Cyclical1.4
Financial Services1.2

Market Cap. Distribution

Callan Capital, LLC has about 22.2% of it's portfolio invested in the large-cap and mega-cap stocks.

78%18%
Category%
UNALLOCATED77.5
MEGA-CAP17.8
LARGE-CAP4.4

Stocks belong to which Index?

About 21.8% of the stocks held by Callan Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

78%22%
Index%
Others78
S&P 50021.8
Top 5 Winners (%)%
HALO
halozyme therapeutics inc
33.3 %
PM
philip morris intl inc
27.1 %
T
at&t inc
21.9 %
ED
consolidated edison inc
21.2 %
EXC
exelon corp
20.7 %
Top 5 Winners ($)$
XLB
select sector spdr tr
0.6 M
VRTX
vertex pharmaceuticals inc
0.4 M
XLB
select sector spdr tr
0.2 M
LLY
eli lilly & co
0.2 M
ABBV
abbvie inc
0.2 M
Top 5 Losers (%)%
TTD
the trade desk inc
-52.8 %
OPI
office pptys income tr
-49.5 %
EQ
equillium inc
-47.6 %
MRVL
marvell technology inc
-44.0 %
QSI
quantum si inc
-36.4 %
Top 5 Losers ($)$
NVDA
nvidia corporation
-5.7 M
AAPL
apple inc
-3.7 M
TSLA
tesla inc
-2.8 M
XLB
select sector spdr tr
-2.4 M
GOOG
alphabet inc
-1.9 M

Callan Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

FNDAMETAFNDAFNDAFNDACWICSDVEUAEMBFNDAAAPLVTEBAEMBGBILNVDAACWFFNDAFNDAVAWBILXLBGBILVE..DFACMSFTXL..CS..VA..GOOGVAWIJRFNDAXLBFNDAAMZNVAWXLBXL..EM..AE..G..C..V....TS..XL..VA..XL..VA..GA..

Current Stock Holdings of Callan Capital, LLC

Callan Capital, LLC has 364 stocks in it's portfolio. About 47.4% of the portfolio is in top 10 stocks. NVDA proved to be the most loss making stock for the portfolio. XLB was the most profitable stock for Callan Capital, LLC last quarter.

Last Reported on: 29 Apr, 2025
TickerNamesorted descending% PortfolioShares Held$ ValueType% ChangeOptions

Historical Trend of SCHWAB STRATEGIC TR Position Held By Callan Capital, LLC

What % of Portfolio is FNDA?:

No data available

Number of FNDA shares held:

No data available

Change in No. of Shares Held:

No data available